{"id":"https://openalex.org/W4408299529","doi":"https://doi.org/10.15406/jdc.2024.08.00277","title":"Clinical insights into Galapep\u2122 infused dark patches corrector: A safe and active approach to manage body hyperpigmentation","display_name":"Clinical insights into Galapep\u2122 infused dark patches corrector: A safe and active approach to manage body hyperpigmentation","publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W4408299529","doi":"https://doi.org/10.15406/jdc.2024.08.00277"},"language":"en","primary_location":{"id":"doi:10.15406/jdc.2024.08.00277","doi":"https://doi.org/10.15406/jdc.2024.08.00277","is_oa":true,"landing_page_url":"https://doi.org/10.15406/jdc.2024.08.00277","pdf_url":"https://medcraveonline.com/JDC/JDC-08-00277.pdf","source":{"id":"https://openalex.org/S4210173853","display_name":"Journal of Dermatology & Cosmetology","issn_l":"2574-9943","issn":["2574-9943"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320093","host_organization_name":"MedCrave Group","host_organization_lineage":["https://openalex.org/P4310320093"],"host_organization_lineage_names":["MedCrave Group"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Dermatology &amp; Cosmetology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://medcraveonline.com/JDC/JDC-08-00277.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051673699","display_name":"Maheshvari N Patel","orcid":"https://orcid.org/0009-0008-8901-6151","observed_orcids":["https://orcid.org/0009-0008-8901-6151"]},"institutions":[{"id":"https://openalex.org/I4405267575","display_name":"NovoBliss Research Private Limited (India)","ror":"https://ror.org/03bnb4m87","country_code":"IN","type":"company","lineage":["https://openalex.org/I4405267575"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Maheshvari Patel","raw_affiliation_strings":["Director \u2013 Operations, NovoBliss Research Private Limited. 313, Gujarat, India","PhD Scholar (Pharmacology), Swaminarayan University, Kalol, India"],"raw_orcid":"https://orcid.org/0009-0008-8901-6151","affiliations":[{"raw_affiliation_string":"Director \u2013 Operations, NovoBliss Research Private Limited. 313, Gujarat, India","institution_ids":["https://openalex.org/I4405267575"]},{"raw_affiliation_string":"PhD Scholar (Pharmacology), Swaminarayan University, Kalol, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111337608","display_name":"Nayan Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267575","display_name":"NovoBliss Research Private Limited (India)","ror":"https://ror.org/03bnb4m87","country_code":"IN","type":"company","lineage":["https://openalex.org/I4405267575"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Nayan Patel","raw_affiliation_strings":["Medical Director, NovoBliss Research Private Limited. 313, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Director, NovoBliss Research Private Limited. 313, India","institution_ids":["https://openalex.org/I4405267575"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070763199","display_name":"Apeksha M. Merja","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267575","display_name":"NovoBliss Research Private Limited (India)","ror":"https://ror.org/03bnb4m87","country_code":"IN","type":"company","lineage":["https://openalex.org/I4405267575"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Apeksha Merja","raw_affiliation_strings":["Sub-Investigator, NovoBliss Research Private Limited. 313, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sub-Investigator, NovoBliss Research Private Limited. 313, India","institution_ids":["https://openalex.org/I4405267575"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112699475","display_name":"Saurav Patnaik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saurav Patnaik","raw_affiliation_strings":["Director-Anveya Living Private Limited, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director-Anveya Living Private Limited, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1423,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.32578323,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"8","issue":"4","first_page":"107","last_page":"113"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.8378999829292297,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.8378999829292297,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.1590999960899353,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyperpigmentation","display_name":"hyperpigmentation","score":0.7979999780654907},{"id":"https://openalex.org/keywords/dark-spots","display_name":"dark spots","score":0.5720000267028809},{"id":"https://openalex.org/keywords/lactic-acid","display_name":"lactic acid","score":0.7749999761581421},{"id":"https://openalex.org/keywords/gallic-acid","display_name":"gallic acid","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nicotinamide","display_name":"nicotinamide","score":1.0},{"id":"https://openalex.org/keywords/tranexamic-acid","display_name":"tranexamic acid","score":1.0},{"id":"https://openalex.org/keywords/retinal","display_name":"retinal","score":0.9879999756813049},{"id":"https://openalex.org/keywords/melanin-reduction","display_name":"melanin reduction","score":0.9520000219345093},{"id":"https://openalex.org/keywords/erythema","display_name":"erythema","score":0.9049999713897705},{"id":"https://openalex.org/keywords/skin-lightening","display_name":"skin lightening","score":0.8989999890327454},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7950000166893005},{"id":"https://openalex.org/keywords/cosmetic-dermatology","display_name":"cosmetic dermatology","score":0.4749999940395355},{"id":"https://openalex.org/keywords/melanogenesis-inhibition","display_name":"melanogenesis inhibition","score":0.5789999961853027},{"id":"https://openalex.org/keywords/skin-tone","display_name":"skin tone","score":0.3050000071525574}],"concepts":[{"id":"https://openalex.org/C2776728111","wikidata":"https://www.wikidata.org/wiki/Q1641068","display_name":"Hyperpigmentation","level":2,"score":0.6858522891998291},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.487882137298584},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.382680207490921}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.15406/jdc.2024.08.00277","doi":"https://doi.org/10.15406/jdc.2024.08.00277","is_oa":true,"landing_page_url":"https://doi.org/10.15406/jdc.2024.08.00277","pdf_url":"https://medcraveonline.com/JDC/JDC-08-00277.pdf","source":{"id":"https://openalex.org/S4210173853","display_name":"Journal of Dermatology & Cosmetology","issn_l":"2574-9943","issn":["2574-9943"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320093","host_organization_name":"MedCrave Group","host_organization_lineage":["https://openalex.org/P4310320093"],"host_organization_lineage_names":["MedCrave Group"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Dermatology &amp; Cosmetology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.15406/jdc.2024.08.00277","doi":"https://doi.org/10.15406/jdc.2024.08.00277","is_oa":true,"landing_page_url":"https://doi.org/10.15406/jdc.2024.08.00277","pdf_url":"https://medcraveonline.com/JDC/JDC-08-00277.pdf","source":{"id":"https://openalex.org/S4210173853","display_name":"Journal of Dermatology & Cosmetology","issn_l":"2574-9943","issn":["2574-9943"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320093","host_organization_name":"MedCrave Group","host_organization_lineage":["https://openalex.org/P4310320093"],"host_organization_lineage_names":["MedCrave Group"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Dermatology &amp; Cosmetology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4408299529.pdf","grobid_xml":"https://content.openalex.org/works/W4408299529.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402994050","https://openalex.org/W7116874496","https://openalex.org/W4387063383","https://openalex.org/W7167498985","https://openalex.org/W4230826352","https://openalex.org/W4293106425","https://openalex.org/W4393316033","https://openalex.org/W4409602973","https://openalex.org/W2016440156","https://openalex.org/W2385216935"],"abstract_inverted_index":{"Introduction:":[0],"Dark":[1,335],"spots,":[2],"also":[3,307],"referred":[4],"to":[5,21,35,52,83,103,220,240,245,286,345],"as":[6,433],"hyperpigmentation,":[7],"are":[8],"regions":[9],"of":[10,24,41,59,111,138,215,230,237,253,262,273,291,296,305,384,422,430],"the":[11,17,26,37,105,112,122,199,204,208,213,216,321,351,364,369,420,428],"skin":[12,30,84,89,401,443],"that":[13,363],"appear":[14],"darker":[15],"than":[16],"surrounding":[18],"areas":[19],"due":[20],"an":[22],"overproduction":[23],"melanin,":[25],"pigment":[27,226],"responsible":[28],"for":[29,115,437],"color.":[31],"This":[32,242,360],"study":[33,102,133,209,361],"aims":[34],"assess":[36],"safety":[38],"and":[39,70,86,108,126,167,178,188,201,255,259,293,298,302,324,356,376,394,441],"effectiveness":[40],"a":[42,48,56,80,192,221,269,282,340,407,416,434],"novel":[43],"depigmentation":[44],"treatment.":[45],"Galapep\u2122":[46,371],"is":[47,339,373],"proprietary":[49],"ingredient":[50],"designed":[51,344],"target":[53,346],"hyperpigmentation":[54,139,440],"through":[55],"synergistic":[57,382],"blend":[58],"active":[60,386],"ingredients,":[61],"including":[62],"lactic":[63],"acid,":[64,66,69,388,390,393],"gallic":[65,389],"niacinamide,":[67,391],"tranexamic":[68,392],"retinaldehyde.":[71],"The":[72,95,132,381],"cream's":[73],"formulation":[74],"targets":[75],"key":[76],"pigmentation":[77],"pathways,":[78],"providing":[79],"comprehensive":[81],"approach":[82],"brightening":[85],"evening":[87],"out":[88],"tone":[90],"in":[91,136,147,224,277,319,378,410,419],"healthy":[92],"participants.":[93],"Methods:":[94],"open-label,":[96],"single-arm,":[97],"single-center,":[98],"prospective,":[99],"interventional":[100],"clinical":[101],"evaluate":[104],"safety,":[106],"efficacy,":[107],"in-use":[109],"tolerability":[110],"test":[113,217,316,328,365],"treatment":[114,218,317,329],"depigmentation.":[116],"Ethical":[117],"approval":[118],"was":[119],"obtained":[120,206],"from":[121,207],"Independent":[123],"Ethics":[124],"Committee,":[125],"all":[127],"participants":[128,414],"provided":[129],"written":[130],"consent.":[131],"assessed":[134],"changes":[135,146],"severity":[137,421],"by":[140,174,268,349],"dermatological":[141],"assessment":[142],"using":[143,153,186],"IGA":[144],"scale,":[145],"melanin":[148,225,358,397],"(pigmentation)":[149],"level,":[150],"erythema":[151,278,411],"index":[152],"instrument":[154],"Mexameter\u00ae":[155],"MX":[156],"18.":[157],"Evaluations":[158],"were":[159,279],"conducted":[160],"at":[161,191],"baseline,":[162],"T30":[163,235,289],"minutes,":[164],"Day":[165,168],"21,":[166],"45":[169,260,303],"post-usage.":[170],"Statistical":[171],"analyses":[172],"performed":[173],"SPSS":[175],"(Version:":[176],"29.0.1.0)":[177],"Microsoft\u00ae":[179],"Excel":[180],"2019":[181],"software,":[182],"with":[183,228,250,281,368,413],"results":[184,205,404],"reported":[185],"p-values":[187,311],"confidence":[189],"intervals":[190],"5%":[193],"significance":[194],"level.":[195],"Results:":[196],"Based":[197],"on":[198],"clinical,":[200],"statistical":[202],"analysis,":[203],"showed":[210],"that:":[211],"Notably,":[212],"application":[214,238],"provides":[219],"remarkable":[222],"reduction":[223,243,409],"levels,":[227,412],"decrease":[229,284],"16.32%":[231],"observed":[232],"immediately":[233],"post":[234,288],"mins":[236,290],"compared":[239,285],"baseline.":[241],"continued":[244],"demonstrate":[246],"efficacy":[247],"over":[248],"time,":[249],"subsequent":[251],"reductions":[252,276,295],"27.64%":[254],"33.84%":[256],"after":[257,300,331],"21":[258,301],"days":[261,304],"continuous":[263],"usage":[264],"respectively,":[265],"each":[266],"accompanied":[267],"highly":[270,309],"significant":[271,310,417],"p-value":[272],"<0.0001.":[274,312],"Similarly,":[275],"observed,":[280],"5.04%":[283],"baseline":[287],"application,":[292],"further":[294,405],"11.50%":[297],"18.12%":[299],"usage,":[306],"displaying":[308],"100%":[313,325],"subjects":[314,326],"experienced":[315,327],"effective":[318,377],"lightening":[320],"dark":[322,347,423],"patches":[323,348],"satisfactory":[330],"use.":[332],"Conclusion:":[333],"ThriveCo":[334],"Patches":[336],"Corrector":[337],"Cream":[338],"clinically":[341],"proven":[342],"solution":[343,436],"exfoliating":[350],"skin,":[352],"promoting":[353,399],"cell":[354],"turnover,":[355],"inhibiting":[357],"production.":[359],"demonstrates":[362],"product,":[366],"formulated":[367],"advanced":[370],"complex,":[372],"both":[374],"safe":[375],"managing":[379],"hyperpigmentation.":[380],"action":[383],"its":[385],"ingredients\u2014lactic":[387],"retinaldehyde\u2014significantly":[395],"reduces":[396],"production,":[398],"even":[400],"tone.":[402],"Clinical":[403],"show":[406],"marked":[408],"experiencing":[415],"improvement":[418],"patches.":[424],"These":[425],"findings":[426],"highlight":[427],"potential":[429],"Galapep\u2122-based":[431],"formulations":[432],"reliable":[435],"safely":[438],"reducing":[439],"improving":[442],"clarity.":[444]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-03-11T00:00:00"}